venBio Partners

Latest statistics and disclosures from venBio Partners's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by venBio Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for venBio Partners

venBio Partners holds 7 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Pharvaris N V (PHVS) 30.9 $161M 4.6M 34.58
 View chart
Parabilis Medicines 27.8 $144M NEW 5.3M 27.37
 View chart
Alumis (ALMS) 24.5 $127M 4.5M 28.14
 View chart
Achieve Life Sciences (ACHV) 7.4 $39M NEW 5.9M 6.53
 View chart
Alx Oncology Hldgs (ALXO) 5.1 $27M 13M 2.07
 View chart
Harmony Biosciences Hldgs In (HRMY) 3.3 $17M -3% 472k 36.41
 View chart
Lyell Immunopharma Com New (LYEL) 0.9 $4.7M 338k 14.05
 View chart

Past Filings by venBio Partners

SEC 13F filings are viewable for venBio Partners going back to 2019

View all past filings